While further investigations are underway to better understand the role of CSPG4 in OSA and to evaluate the efficacy of its immune-targeting in combinatorial approaches with the standard of care (personal communication), focusing on a single molecular target carries the risk of tumor escape. Here, CSPG4 is linked to neoplasm.